FutureHouse has announced a significant breakthrough with its multi-agent system, Robin, which has successfully automated the scientific discovery process, leading to the identification of ripasudil as a novel treatment for dry age-related macular degeneration (dAMD). The system integrates various AI agents to autonomously generate hypotheses, design experiments, and analyze data, demonstrating a new paradigm for AI-driven research across multiple scientific fields. The code and data for Robin will be released for public use to encourage further advancements in automated discovery.